a continuous 45 day treatment ( interferon renewed three times a week ) with 10 , 10 ( 2 ) or 10 ( 3 ) u/ml of ifn-alpha 2 or -gamma combined with a fixed high dose ( 10 ( 3 ) u/ml ) of either ifn-alpha 2 or -gamma resulted in an additive or synergistic growth inhibition according to the doses used .
C0021747
interferon
C0021734
ifn-alpha 2